waters corp. - WAT
WAT
Close Chg Chg %
344.65 13.05 3.79%
Closed Market
357.70
+13.05 (3.79%)
Volume: 688.88K
Last Updated:
Nov 20, 2024, 3:59 PM EDT
Company Overview: waters corp. - WAT
WAT Key Data
| Open $341.79 | Day Range 340.62 - 358.04 |
| 52 Week Range 269.05 - 398.45 | Market Cap $20.47B |
| Shares Outstanding 59.38M | Public Float N/A |
| Beta 0.97 | Rev. Per Employee N/A |
| P/E Ratio 32.89 | EPS $10.51 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 542.04K |
WAT Performance
| 1 Week | -0.19% | ||
| 1 Month | 2.67% | ||
| 3 Months | 4.48% | ||
| 1 Year | 27.60% | ||
| 5 Years | 63.57% |
WAT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
20
Full Ratings ➔
About waters corp. - WAT
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
WAT At a Glance
Waters Corp.
34 Maple Street
Milford, Massachusetts 01757
| Phone | 1-508-478-2000 | Revenue | 2.96B | |
| Industry | Medical Specialties | Net Income | 642.23M | |
| Sector | Health Technology | Employees | 7,900 | |
| Fiscal Year-end | 12 / 2024 | |||
| View SEC Filings |
WAT Valuation
| P/E Current | 32.893 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 30.384 |
| Price to Sales Ratio | 6.60 |
| Price to Book Ratio | 16.936 |
| Price to Cash Flow Ratio | 32.371 |
| Enterprise Value to EBITDA | 21.357 |
| Enterprise Value to Sales | 7.293 |
| Total Debt to Enterprise Value | 0.113 |
WAT Efficiency
| Revenue/Employee | 374,229.873 |
| Income Per Employee | 81,295.443 |
| Receivables Turnover | 4.21 |
| Total Asset Turnover | 0.748 |
WAT Liquidity
| Current Ratio | 2.22 |
| Quick Ratio | 1.566 |
| Cash Ratio | 0.501 |
WAT Profitability
| Gross Margin | 58.468 |
| Operating Margin | 28.535 |
| Pretax Margin | 24.903 |
| Net Margin | 21.723 |
| Return on Assets | 16.242 |
| Return on Equity | 77.619 |
| Return on Total Capital | 17.877 |
| Return on Invested Capital | 22.911 |
WAT Capital Structure
| Total Debt to Total Equity | 212.308 |
| Total Debt to Total Capital | 67.98 |
| Total Debt to Total Assets | 52.785 |
| Long-Term Debt to Equity | 205.542 |
| Long-Term Debt to Total Capital | 65.814 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Waters Corp. - WAT
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 2.37B | 2.79B | 2.97B | 2.96B | |
Sales Growth
| -1.71% | +17.78% | +6.68% | -0.52% | |
Cost of Goods Sold (COGS) incl D&A
| 1.02B | 1.16B | 1.25B | 1.23B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 125.36M | 131.68M | 130.42M | 165.91M | |
Depreciation
| 68.69M | 71.56M | 72.00M | 84.63M | |
Amortization of Intangibles
| 56.68M | 60.12M | 58.42M | 81.28M | |
COGS Growth
| +0.48% | +13.82% | +7.68% | -1.81% | |
Gross Income
| 1.34B | 1.62B | 1.72B | 1.73B | |
Gross Income Growth
| -3.31% | +20.78% | +5.97% | +0.41% | |
Gross Profit Margin
| +56.86% | +58.31% | +57.92% | +58.47% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 667.48M | 795.33M | 834.22M | 884.96M | |
Research & Development
| 140.78M | 168.36M | 176.19M | 174.94M | |
Other SG&A
| 526.70M | 626.97M | 658.03M | 710.01M | |
SGA Growth
| -0.04% | +19.15% | +4.89% | +6.08% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 33.46M | (4.49M) | 15.97M | 26.16M | |
EBIT after Unusual Expense
| 644.04M | 833.68M | 871.25M | 817.45M | |
Non Operating Income/Expense
| 15.94M | 17.45M | 15.39M | 17.65M | |
Non-Operating Interest Income
| 16.27M | 12.22M | 11.02M | 16.62M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 49.07M | 44.94M | 48.80M | 98.86M | |
Interest Expense Growth
| +0.78% | -8.42% | +8.59% | +102.60% | |
Gross Interest Expense
| 49.07M | 44.94M | 48.80M | 98.86M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 610.91M | 806.19M | 837.85M | 736.24M | |
Pretax Income Growth
| -9.93% | +31.97% | +3.93% | -12.13% | |
Pretax Margin
| +25.83% | +28.94% | +28.19% | +24.90% | |
Income Tax
| 89.34M | 113.35M | 130.09M | 94.01M | |
Income Tax - Current - Domestic
| 32.63M | 19.99M | 70.18M | 6.61M | |
Income Tax - Current - Foreign
| 59.41M | 76.72M | 91.90M | 88.60M | |
Income Tax - Deferred - Domestic
| (8.75M) | 10.84M | (30.97M) | (5.49M) | |
Income Tax - Deferred - Foreign
| 6.06M | 5.80M | (1.02M) | 4.29M | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 521.57M | 692.84M | 707.75M | 642.23M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 521.57M | 692.84M | 707.75M | 642.23M | |
Net Income Growth
| -11.93% | +32.84% | +2.15% | -9.26% | |
Net Margin Growth
| +22.05% | +24.87% | +23.81% | +21.72% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 521.57M | 692.84M | 707.75M | 642.23M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 521.57M | 692.84M | 707.75M | 642.23M | |
EPS (Basic)
| 8.3997 | 11.252 | 11.7989 | 10.8713 | |
EPS (Basic) Growth
| -4.08% | +33.96% | +4.86% | -7.86% | |
Basic Shares Outstanding
| 62.09M | 61.58M | 59.98M | 59.08M | |
EPS (Diluted)
| 8.3566 | 11.1698 | 11.7312 | 10.8357 | |
EPS (Diluted) Growth
| -3.81% | +33.66% | +5.03% | -7.63% | |
Diluted Shares Outstanding
| 62.41M | 62.03M | 60.33M | 59.27M | |
EBITDA
| 802.87M | 960.87M | 1.02B | 1.01B | |
EBITDA Growth
| -3.11% | +19.68% | +5.91% | -0.80% | |
EBITDA Margin
| +33.94% | +34.49% | +34.24% | +34.15% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 351.188 | |
| Number of Ratings | 20 | Current Quarters Estimate | 4.031 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 11.796 | |
| Last Quarter’s Earnings | 2.93 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 11.75 | Next Fiscal Year Estimate | 12.924 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 19 | 14 | 19 | 19 |
| Mean Estimate | 4.03 | 2.44 | 11.80 | 12.92 |
| High Estimates | 4.07 | 2.82 | 11.84 | 13.21 |
| Low Estimate | 3.99 | 2.31 | 11.76 | 12.71 |
| Coefficient of Variance | 0.63 | 5.19 | 0.22 | 1.18 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 2 |
| OVERWEIGHT | 0 | 1 | 0 |
| HOLD | 15 | 16 | 19 |
| UNDERWEIGHT | 1 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Waters Corp. - WAT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Waters Corp. - WAT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 16, 2024 | Heather Knight Director | 349 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 16, 2024 | Heather Knight Director | 136 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 26, 2024 | Robert L. Carpio SVP, Waters Division | 5,537 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 26, 2024 | Robert L. Carpio SVP, Waters Division | 4,494 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 29, 2024 | Richard H. Fearon Director | 1,653 | Open market or private purchase of non-derivative security Non-derivative transaction at $332.9 per share | 550,283.70 |
| May 16, 2024 | Christopher A. Kuebler Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 16, 2024 | Christopher A. Kuebler Director | 14,716 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $361.64 per share | 5,321,894.24 |
| May 16, 2024 | Christopher A. Kuebler Director | 18,716 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $113.88 per share | 2,131,378.08 |
| May 15, 2024 | Amol Chaubal SVP & Chief Financial Officer | 2,294 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $349.28 per share | 801,248.32 |
| Apr 9, 2024 | Jianqing Y. Bennett SVP TA Instruments Division | 2,772 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $335.94 per share | 931,225.68 |
| Apr 2, 2024 | Pearl Shirley Huang Director | 75 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 2, 2024 | Wei Jiang Director | 62 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2024 | Linda Baddour Director | 2,250 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $355.54 per share | 799,965.00 |
| Mar 4, 2024 | Udit Batra President and CEO; Director | 12,579 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $346.04 per share | 4,352,837.16 |
| Mar 4, 2024 | Udit Batra President and CEO; Director | 8,941 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $346.04 per share | 3,093,943.64 |
| Feb 9, 2024 | Jianqing Y. Bennett SVP TA Instruments Division | 5,759 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 9, 2024 | Amol Chaubal SVP & Chief Financial Officer | 8,228 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |